Fabtech Technologies of Mumbai, India, has won a project for a avian influenza (bird flu) vaccine facility In Egypt.
The US$19m project will produce 400 million doses of the avian influenza vaccine in the first year and over 800 million doses from the second year onwards.
The project is scheduled to be completed in 18 months and is funded by a loan of $15m from development partners Hassan of the Islamic Development Bank and another loan of $4m from the Saudi finance fund.
Dr Khalid Mujahid, spokesperson for the Ministry of Health in Egypt and the Health Minister Dr Ahmed Imad Eddin witnessed the signing of the contract between Vacsera (Egyvet) and Fabtech.
Fabtech is a global engineering and fabrication company with a strong presence in Asia, Middle East and the US. It specialises in innovative turnkey solutions for the pharmaceutical, biotechnology and healthcare sectors and has more than 700 installations in 42 plus countries.
The company now provides a complete turnkey solution and has its own manufacturing setup for pre-fabricated panels.
